Skip to main content
Caplight Logo









PulseCath B.V.

PulseCath B.V.

Private
ArnhemHealthcare & Life Scienceshttps://www.pulsecath.com/

Last Round

Grant

Jun 1, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

PulseCath B.V. is a medical device company that develops, manufactures, and markets percutaneous mechanical circulatory support systems for cardiologists and cardiac surgeons.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

mechanical circulatory supportMCSleft ventricular assist deviceLVADpercutaneous heart pumppulsatile flowhemodynamic supportinterventional cardiologycardiogenic shockpercutaneous coronary interventionPCIcardiac unloadingminimally invasive cardiologycatheter-based device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PulseCath B.V. Comparables

Compare PulseCath B.V. with similar companies based on industry and business-model similarity.

PulseCath B.V. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Procyrion
88%
Johnson & Johnson
82%
Supira Medical
81%

PulseCath B.V. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 1, 2025
StrategicSep 17, 2021

Key People

Founding team and executive leadership

Oren Malchin

Chief Executive Officer

Executive Team

yoram karmon

President & CEO

Executive Team

PulseCath B.V. Investors

Notable investors and investment history

PulseCath B.V. investors
InvestorRounds
Eurostars SME programmeGrant
MedSciences CapitalStrategic
East Netherlands Development Agency (Oost NL)Strategic
Health InnovationsStrategic

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 46% MoM.

  • Jun 19, 2026

    Monthly visitors grew 99% MoM, reaching 2K.

PulseCath B.V. Filings

Explore SEC and related filing metadata, where available.

PulseCath B.V. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PulseCath B.V.'s valuation, stock price, and market status.

Is PulseCath B.V. a public or private company?

PulseCath B.V. is a private company.

What is the current stock price of PulseCath B.V.?

PulseCath B.V. is a private company with no public stock price. No recent secondary market data is available.

How much is PulseCath B.V. worth (valuation)?

Valuation information for PulseCath B.V. is not publicly available.

Can I buy PulseCath B.V. stock?

PulseCath B.V. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PulseCath B.V.'s last funding round?

PulseCath B.V.'s most recent funding round was Grant on June 1, 2025.

Who are the main investors in PulseCath B.V.?

Key investors in PulseCath B.V. include Eurostars SME programme, MedSciences Capital, East Netherlands Development Agency (Oost NL), Health Innovations.

Will PulseCath B.V. IPO soon?

No public IPO plans have been announced for PulseCath B.V..

How can I track PulseCath B.V. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PulseCath B.V.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersArnhem
Employee Range13
Year Founded2007
Last FundingJun 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?